Piero Dalerba, MD
Overview
Email: pdd2109@cumc.columbia.edu
Academic Appointments
- Assistant Professor of Pathology & Cell Biology
Languages
- Italian
Credentials & Experience
Education & Training
- MD, 1995 University of Milan (Italy)
Honors & Awards
2017
Schaefer Research Scholar - Columbia University Medical Center (CUMC)
2016
Runyon-Rachleff Innovation Award - Damon Runyon Cancer Research Foundation
2012
NCCN Young Investigator Award - National Comprehensive Cancer Network (NCCN)
2012
Siebel Scholars Program - Siebel Stem Cell Institute and The Thomas and Stacey Siebel Foundation
2011
BD Biosciences Stem Cell Research Grant - BD Biosciences
2006
CIRM Training Grant - California Institute for Regenerative Medicine (CIRM)
2004
FIRC “Leonino Fontana e Maria Lionello” Fellowship - Italian Foundation for Cancer Research (FIRC)
2002
9th International PBI “Valentina Lana” Research Prize in Molecular Immunology - Italian Society for Immunology, Clinical Immunology and Allergology (SIICA)
2001
FIRC Research Fellowship - Italian Foundation for Cancer Research (FIRC)
1996
MURST Clinical Fellowship - Italian Ministry for Scientific and Technological Research (MURST)
Research
"Considerate la vostra semenza, nati non foste a viver come bruti, ma per seguir virtute e canoscenza." Dante, Inferno, Canto XXVI, 118-120
a) Application of single-cell technologies for the analysis of tissue cell composition, with a special focus on the identification and molecular characterization of human colon and breast "cancer stem cells" and their normal counterparts (i.e. normal colon epithelial and breast epithelial stem cells); b) Identification and clinical development of novel predictive biomarkers to guide therapeutic algorithm design in human colon and breast cancer.
Research Interests
- Application of single-cell technologies for the analysis of tissue cell composition
- Novel predictive biomarkers to guide therapeutic algorithm design in human colon and breast cancer
Selected Publications
Dalerba P. The dynamic identity of intestinal cancer stem cells. Cell Stem Cell, 20:743-745 (2017). PubMed ID: 28575688
Dalerba P., Sahoo D., Paik S., Guo X., Yothers G., Song N., Wilcox-Fogel N., Forgo' E., Rajendran P.S., Miranda S.P., Hisamori S., Hutchison J., Kalisky T., Qian D., Wolmark N., Fisher G.A., van de Rijn M. and Clarke M.F. CDX2 as a prognostic biomarker in Stage-II and Stage-III colon cancer. The New England Journal of Medicine (N.E.J.M.), 374:211-222 (2016). PubMed ID: 26789870
Cominelli M., Grisanti S., Mazzoleni S., Branca C., Buttolo L., Furlan D., Liserre B., Bonetti M.F., Medicina D., Pellegrini V., Buglione M., Liserre R., Pellegatta S., Finocchiaro G., Dalerba P., Facchetti F., Pizzi M., Galli R. and Poliani P.L. EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide. Journal of the National Cancer Institute (J.N.C.I.), 107:djv041 (2015). PubMed ID: 25739547
Wu A.R., Neff N.F., Kalisky T., Dalerba P., Treutlein B., Rothenberg M.E., Mburu F.M., Mantalas G.L., Sim S., Clarke M.F. and Quake S.R. Quantitative assessment of single-cell RNA-sequencing methods. Nature Methods, 11:41-46 (2014). PubMed ID: 24141493
Dalerba P. and Clarke M.F. Oncogenic miRNAs and the perils of losing control of a stem cell's epigenetic identity. Cell Stem Cell, 13:5-6 (2013). PubMed ID: 23827702
Willingham S., Volkmer J.P., Gentles A.J., Sahoo D., Dalerba P., Mitra S.S., Wang J., Contreras-Trujillo H., Martin R., Cohen J.D., Lovelace P., Scheeren F.A., Chao M.P., Weisskopf K., Tang C., Naik T.J., Volkmer A., Storm T.A., Mosley A.R., Edris B., Schmid S.M., Sun C.K., Chua M.S., Murillo O., Rajendran P.S., Cha A.C., Chin R.K., Kim D., Adorno M., Raveh T., Tseng D., Jaiswal S., Enger P.O., Steinberg G.K., Li G., So S.K., Majeti R., Harsh G.R., van de Rijn M., Teng N., Sunwoo J.B., Alizadeh A.A., Clarke M.F. and. Weissman I.L. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proceedings of the National Academy of Sciences of the USA (P.N.A.S.), 109:6662-6667 (2012). PubMed ID: 22451913
Dalerba P., Kalisky T., Sahoo D., Rajendran P.S., Rothenberg M.E., Leyrat A.A., Sim S., Okamoto J., Johnston D.M., Qian D., Zabala M., Bueno J., Neff N.F., Wang J., Shelton A.A., Visser B., Hisamori S., Shimono Y., van de Wetering M., Clevers H., Clarke M.F. and Quake S.R. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nature Biotechnology, 29:1120-1127 (2011). PubMed ID: 22081019
Shimono Y., Zabala M., Cho R.W., Lobo N.A., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K. and Clarke M.F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell, 138:592-603 (2009). PubMed ID: 19665978
Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., Hoey T., Gurney A., Huang E.H., Simeone D.M., Shelton A.A., Parmiani G., Castelli C. and Clarke M.F. Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences of the USA (P.N.A.S.), 104:10158-10163 (2007). PubMed ID: 17548814
Liu R., Wang X., Chen G.Y., Dalerba P., Gurney A., Hoey T., Sherlock G., Lewicki J., Shedden K. and Clarke M.F. The prognostic role of a gene signature from tumorigenic breast cancer cells. The New England Journal of Medicine (N.E.J.M.), 356:217-226 (2007). PubMed ID: 17229949
Dalerba P. and Clarke M.F. Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell, 1:241-242 (2007). PubMed ID: 18371356
Dalerba P., Cho R.W. and Clarke M.F. Cancer stem cells: models and concepts. Annual Review of Medicine, 58:267-284 (2007). PubMed ID: 17002552
Dalerba P., Guiducci C., Poliani P.L., Cifola I., Parenza M., Frattini M., Gallino G., Carnevali I., Di Giulio I., Andreola S., Lombardo C., Rivoltini L., Schweighoffer T., Belli F., Colombo M.P., Parmiani G. and Castelli C. Reconstitution of human telomerase reverse transcriptase (hTERT) expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. Cancer Research, 65:2321-2329 (2005). PubMed ID: 15781646
For a complete list of publications, please visit PubMed.gov